
Eric Olson
Examiner (ID: 15792, Phone: (571)272-9051 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1673, 1623, 1693 |
| Total Applications | 1700 |
| Issued Applications | 960 |
| Pending Applications | 118 |
| Abandoned Applications | 631 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14893967
[patent_doc_number] => 20190290749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => IMMUNE MODULATOR AND VACCINE COMPOSITION CONTAINING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/345699
[patent_app_country] => US
[patent_app_date] => 2017-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7892
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16345699
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/345699 | Immune modulator and vaccine composition containing the same | Oct 29, 2017 | Issued |
Array
(
[id] => 12707968
[patent_doc_number] => 20180127822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => MODIFIED NUCLEOTIDES METHODS AND KITS
[patent_app_type] => utility
[patent_app_number] => 15/792875
[patent_app_country] => US
[patent_app_date] => 2017-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18935
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15792875
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/792875 | Modified nucleotides methods and kits | Oct 24, 2017 | Issued |
Array
(
[id] => 17290931
[patent_doc_number] => 20210386770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => THERAPEUTIC AGENTS AND METHODS OF PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 16/341777
[patent_app_country] => US
[patent_app_date] => 2017-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39443
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16341777
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/341777 | Therapeutic agents and methods of producing same | Oct 11, 2017 | Issued |
Array
(
[id] => 12580899
[patent_doc_number] => 20180085462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-29
[patent_title] => TOPICAL USE OF LEVOFLOXACIN FOR REDUCING LUNG INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 15/729930
[patent_app_country] => US
[patent_app_date] => 2017-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9998
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15729930
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/729930 | Topical use of levofloxacin for reducing lung inflammation | Oct 10, 2017 | Issued |
Array
(
[id] => 16175375
[patent_doc_number] => 20200222343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => METFORMIN AMINO ACID COMPOUNDS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/337994
[patent_app_country] => US
[patent_app_date] => 2017-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59755
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16337994
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/337994 | Metformin amino acid compounds and methods of using the same | Sep 28, 2017 | Issued |
Array
(
[id] => 12260864
[patent_doc_number] => 20180080059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-22
[patent_title] => 'DETECTION OF OLIGOSACCHARIDES'
[patent_app_type] => utility
[patent_app_number] => 15/705677
[patent_app_country] => US
[patent_app_date] => 2017-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 24640
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15705677
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/705677 | Detection of oligosaccharides | Sep 14, 2017 | Issued |
Array
(
[id] => 13424967
[patent_doc_number] => 20180264026
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => IMMUNOMODULATING COMPOUNDS AND RELATED COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 15/706604
[patent_app_country] => US
[patent_app_date] => 2017-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19683
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15706604
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/706604 | IMMUNOMODULATING COMPOUNDS AND RELATED COMPOSITIONS AND METHODS | Sep 14, 2017 | Abandoned |
Array
(
[id] => 14563999
[patent_doc_number] => 20190209606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => SITU GELLING COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF INFLAMMATION AND TISSUE DAMAGE
[patent_app_type] => utility
[patent_app_number] => 16/333434
[patent_app_country] => US
[patent_app_date] => 2017-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13451
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16333434
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/333434 | In situ gelling compositions for the treatment or prevention of inflammation and tissue damage | Sep 13, 2017 | Issued |
Array
(
[id] => 16304132
[patent_doc_number] => 10772903
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-15
[patent_title] => Targeting fungi in combination with cancer therapy
[patent_app_type] => utility
[patent_app_number] => 15/702141
[patent_app_country] => US
[patent_app_date] => 2017-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 56
[patent_no_of_words] => 16274
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15702141
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/702141 | Targeting fungi in combination with cancer therapy | Sep 11, 2017 | Issued |
Array
(
[id] => 16238314
[patent_doc_number] => 20200255548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => Nanofibrillated Cellulose Fibers
[patent_app_type] => utility
[patent_app_number] => 16/642665
[patent_app_country] => US
[patent_app_date] => 2017-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7381
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16642665
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/642665 | Nanofibrillated Cellulose Fibers | Aug 30, 2017 | Abandoned |
Array
(
[id] => 15816593
[patent_doc_number] => 10633462
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-28
[patent_title] => Manufacturing process for cyclodextrin derivatives
[patent_app_type] => utility
[patent_app_number] => 15/693248
[patent_app_country] => US
[patent_app_date] => 2017-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 18
[patent_no_of_words] => 29487
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15693248
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/693248 | Manufacturing process for cyclodextrin derivatives | Aug 30, 2017 | Issued |
Array
(
[id] => 14463013
[patent_doc_number] => 20190183145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => USE OF HUMAN MILK OLIGOSACCHARIDES IN CALVES FATTENING
[patent_app_type] => utility
[patent_app_number] => 16/328850
[patent_app_country] => US
[patent_app_date] => 2017-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2876
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16328850
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/328850 | USE OF HUMAN MILK OLIGOSACCHARIDES IN CALVES FATTENING | Aug 28, 2017 | Abandoned |
Array
(
[id] => 12184021
[patent_doc_number] => 20180042958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'GALACTOSE-PRONGED POLYSACCHARIDES IN A FORMULATION FOR ANTIFIBROTIC THERAPIES'
[patent_app_type] => utility
[patent_app_number] => 15/688009
[patent_app_country] => US
[patent_app_date] => 2017-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8977
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15688009
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/688009 | Galactose-pronged polysaccharides in a formulation for antifibrotic therapies | Aug 27, 2017 | Issued |
Array
(
[id] => 18620610
[patent_doc_number] => 11753638
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-12
[patent_title] => Conjugated oligonucleotides
[patent_app_type] => utility
[patent_app_number] => 16/322212
[patent_app_country] => US
[patent_app_date] => 2017-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 97
[patent_figures_cnt] => 105
[patent_no_of_words] => 27673
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16322212
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/322212 | Conjugated oligonucleotides | Aug 10, 2017 | Issued |
Array
(
[id] => 14497781
[patent_doc_number] => 20190192545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => COMPOSITIONS AND THE USE THEREOF FOR TREATING OR PREVENTING ROSACEA
[patent_app_type] => utility
[patent_app_number] => 16/322434
[patent_app_country] => US
[patent_app_date] => 2017-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4352
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16322434
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/322434 | Compositions and the use thereof for treating or preventing rosacea | Aug 3, 2017 | Issued |
Array
(
[id] => 17141678
[patent_doc_number] => 20210309690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => OLIGONUCLEOTIDE SYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 16/320918
[patent_app_country] => US
[patent_app_date] => 2017-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8548
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16320918
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/320918 | OLIGONUCLEOTIDE SYNTHESIS | Jul 24, 2017 | Abandoned |
Array
(
[id] => 12030805
[patent_doc_number] => 20170320904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'PRECIPITATION PROMOTER AND PRECIPITATION METHOD IN WHICH SAME IS USED'
[patent_app_type] => utility
[patent_app_number] => 15/655280
[patent_app_country] => US
[patent_app_date] => 2017-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35243
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15655280
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/655280 | Precipitation promoter and precipitation method in which same is used | Jul 19, 2017 | Issued |
Array
(
[id] => 14438937
[patent_doc_number] => 20190177341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => BORON-CONTAINING COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/320989
[patent_app_country] => US
[patent_app_date] => 2017-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8246
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16320989
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/320989 | Boron-containing compound | Jul 19, 2017 | Issued |
Array
(
[id] => 16125937
[patent_doc_number] => 10696709
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-30
[patent_title] => Phosphotriazole MRNA 5'-end cap analogs, composition comprising the same, RNA molecule incorporating the same, uses thereof and method of synthesizing RNA molecule, protein or peptide
[patent_app_type] => utility
[patent_app_number] => 16/318126
[patent_app_country] => US
[patent_app_date] => 2017-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13589
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16318126
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/318126 | Phosphotriazole MRNA 5'-end cap analogs, composition comprising the same, RNA molecule incorporating the same, uses thereof and method of synthesizing RNA molecule, protein or peptide | Jul 11, 2017 | Issued |
Array
(
[id] => 12000196
[patent_doc_number] => 20170304351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'COMBINATION THERAPY FOR THE TREATMENT OF DEPRESSION AND OTHER NON-INFECTIOUS DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/647198
[patent_app_country] => US
[patent_app_date] => 2017-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12045
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15647198
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/647198 | COMBINATION THERAPY FOR THE TREATMENT OF DEPRESSION AND OTHER NON-INFECTIOUS DISEASES | Jul 10, 2017 | Abandoned |